𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety Profile and Metabolic Effects of 14 Days of Treatment with DIO-902: Results of a Phase IIa Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial in Patients with Type 2 Diabetes Mellitus

✍ Scribed by Sherwyn L. Schwartz; Marc Rendell; Andrew J. Ahmann; Asha Thomas; Carlos J. Arauz-Pacheco; Bernice R. Welles


Book ID
116372179
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
118 KB
Volume
30
Category
Article
ISSN
0149-2918

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES